JPM vs NBXG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
NBXG presents a stark contrast between deep value and poor fundamental health, characterized by a critical Piotroski F-Score of 1/9. While the current price of $14.58 trades at a significant discount to its growth-based intrinsic value of $28.56 and offers a robust 9.88% dividend yield, the deterministic health markers are severely weak. The combination of a bearish technical trend (0/100) and low insider sentiment (40/100) offsets the attractive valuation metrics. Consequently, the asset is viewed as a high-yield value play with significant underlying fundamental risks.
Compare Another Pair
Related Comparisons
JPM vs NBXG: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Neuberger Berman Income Funds - Neuberger Next Generation Connectivity Fund Inc. (NBXG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.